C RICHARD KRAMLICH Insider Trading $CLVS Clovis Oncology, Inc.
Get free email notifications about insider trading for C RICHARD KRAMLICH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of C RICHARD KRAMLICH. C RICHARD KRAMLICH is Director in SIERRA MONITOR CORP /CA/ ($SRMC) and Director in ZHONE TECHNOLOGIES INC ($ZHNE) and 10% Owner in AMICUS THERAPEUTICS INC ($FOLD) and 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in INHIBITEX, INC. ($INHX) and 10% Owner in VONAGE HOLDINGS CORP ($VG) and Director in XOOM Corp ($XOOM) and 10% Owner in Workday, Inc. ($WDAY) and 10% Owner in INNERWORKINGS INC ($INWK) and 10% Owner in Millennial Media Inc. ($MM) and 10% Owner in FUSION-IO, INC. ($FIO) and 10% Owner in HYPERION THERAPEUTICS INC ($HPTX) and 10% Owner in Echo Global Logistics, Inc. ($ECHO) and 10% Owner in Clovis Oncology, Inc. ($CLVS) and Director in Financial Engines, Inc. ($FNGN) and 10% Owner in TESARO, Inc. ($TSRO).
C RICHARD KRAMLICH in Clovis Oncology, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of C RICHARD KRAMLICH: 10% Owner
Holdings: 3,419,671 shares
Current Value: $205,180,260
Latest Transaction: Nov 22 2011
$CLVS Market Capitalization: $2.45B
$CLVS Previous Close: $60.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of C RICHARD KRAMLICH in Clovis Oncology, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FOLD, CBIO, CLVS, DZSI, ECHO, FNGN, FIO, HPTX, INHX, INWK, MM, SRMC, TSRO, VG, WDAY, XOOM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 22 2011 | CLVS | Clovis Oncology, I ... | KRAMLICH C RICHARD | 10% Owner | Option Exercise | C | 0.00 | 377,124 | 0 | 0 | |
| Nov 22 2011 | CLVS | Clovis Oncology, I ... | KRAMLICH C RICHARD | 10% Owner | Option Exercise | C | 0.00 | 2,612,330 | 0 | 0 | |
| Nov 22 2011 | CLVS | Clovis Oncology, I ... | KRAMLICH C RICHARD | 10% Owner | Option Exercise | C | 0.00 | 1,206,897 | 0 | 0 | |
| Nov 22 2011 | CLVS | Clovis Oncology, I ... | KRAMLICH C RICHARD | 10% Owner | Option Exercise | C | 0.00 | 1,186,897 | 0 | 0 | |
| Nov 22 2011 | CLVS | Clovis Oncology, I ... | KRAMLICH C RICHARD | 10% Owner | Buy | P | 13.00 | 1,316,299 | 17,111,887 | 3,419,671 | 2.1 M to 3.4 M (+62.58 %) |
| Nov 22 2011 | CLVS | Clovis Oncology, I ... | KRAMLICH C RICHARD | 10% Owner | Buy | C | 0.00 | 377,124 | 0 | 2,103,372 | 1.7 M to 2.1 M (+21.85 %) |
| Nov 22 2011 | CLVS | Clovis Oncology, I ... | KRAMLICH C RICHARD | 10% Owner | Buy | C | 0.00 | 1,726,248 | 0 | 1,726,248 | 0 to 1.7 M |
Page: 1